2017
DOI: 10.3329/bjms.v16i1.31139
|View full text |Cite
|
Sign up to set email alerts
|

The effect of quercetin and doxorubicin combination in inhibiting resistance in mcf-7 cell

Abstract: Abstract:Background: Doxorubicin chemotherapy may induce the development of resistance in the cancer cells. Overexpression of P-glycoprotein (P-gp) has prominent causative role in this process. Unfortunately, many inhibitory agents do not exert satisfying clinical outcome to overcome resistance. Quercetin, a polyphenolic compound, can be developed as P-gp inhibitor due to its cytotoxic properties. Objective: To investigate the effect of quercetin and doxorubicin combination in inhibiting the development of res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 20 publications
0
11
0
Order By: Relevance
“…Silymarin as a complex is generally known for its inhibitory effects on P-gp transporter [46][47][48]. Also, the combination of one silymarin component-quercetin with doxorubicin-significantly increased the doxorubicin sensitivity of doxorubicin-resistant breast cancer (MCF-7) cells and quercetin also decreased P-gp expression [49]. We noticed strong P-gp ATPase inhibition activity of all silybins and dehydrosilybins in a dose-dependent manner.…”
Section: Discussionmentioning
confidence: 65%
“…Silymarin as a complex is generally known for its inhibitory effects on P-gp transporter [46][47][48]. Also, the combination of one silymarin component-quercetin with doxorubicin-significantly increased the doxorubicin sensitivity of doxorubicin-resistant breast cancer (MCF-7) cells and quercetin also decreased P-gp expression [49]. We noticed strong P-gp ATPase inhibition activity of all silybins and dehydrosilybins in a dose-dependent manner.…”
Section: Discussionmentioning
confidence: 65%
“…The most commonly used breast cancer resistant 2D cell culture model is the MCF-7/ ADR cells. [36,65,66] These cells are generally obtained by maintaining MCF-7 cells in culture medium supplemented with DOX for long periods of time. [33,34,36] For instance, Desrini et al obtained Doxorubicin resistant MCF-7 cell by exposing parental MCF-7 cells to DOX twice a week for a period of 25 days.…”
Section: Resultsmentioning
confidence: 99%
“…[36,65,66] These cells are generally obtained by maintaining MCF-7 cells in culture medium supplemented with DOX for long periods of time. [33,34,36] For instance, Desrini et al obtained Doxorubicin resistant MCF-7 cell by exposing parental MCF-7 cells to DOX twice a week for a period of 25 days. [36] Optionally, resistant MCF-7 cells can also be obtained by exposing them to hypoxic cycles (e.g., <1% oxygen), [37,38] since the hypoxia triggers the activation of a plethora of molecular pathways involved in cancer cells' resistance (reviewed in refs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been known for a long time that flavonoids can modulate both expression and activity of many ABC transporters, with some relevant impact on drug resistance [ 20 , 21 , 22 ]. Quercetin has been also reported to modulate the activity of some members of the multidrug-resistance transporters family such as P-gp [ 23 , 24 , 25 , 26 , 27 , 28 ], ABCC1 [ 27 , 29 ], ABCC2, and ABCG2 [ 27 ]. ABCC6 is a member of the C subfamily of ATP-binding cassette transporters mainly expressed in liver and kidney, poorly involved in drug resistance [ 30 , 31 , 32 ].…”
Section: Introductionmentioning
confidence: 99%